Quantitative and qualitative evaluation of liver metastases with intraprocedural cone beam CT prior to transarterial radioembolization as a predictor of treatment response - 21/09/22
Abstract |
Purpose |
To investigate, by quantitative and qualitative enhancement measurements, the correlation between tumor enhancement on cone beam computed tomography (CBCT) images and treatment response at 6 months in patients undergoing transarterial radioembolization (TARE) for liver metastases.
Materials and Methods |
36 patients (56% male; median age 62.5 years) with 104 metastases were retrospectively included. Quantitative and qualitative enhancement of liver metastases were evaluated on CBCT images before TARE. Quantitative analysis consisted of lesion enhancement measurements (ROI HU lesion – ROI HU relative to inferior vena cava). Qualitative analysis consisted of subjective enhancement pattern analysis (diffuse, sparse, rim-like or non-enhancing). Morphologic tumor response was evaluated according to RECIST 1.1 criteria on follow-up CT or MR imaging.
Results |
At a mean follow up of 6.5 ± 3.7 months, progressive disease (PD) was found in 4 patients, partial response (PR) in 11 and stable disease (SD) in 21. Relative lesion enhancement was significantly different between these groups (-37.5±154.2 HU vs. 103.8±93.4 vs. 181±144 HU in PD vs. SD vs. PR group, respectively; p<0.01). ROC analysis of relative lesion enhancement to predict progressive disease showed an area under the curve of 0.86 (p<0.01). For qualitative lesion enhancement analysis, no difference between groups was found.
Conclusion |
Quantitative enhancement measurements derived from intraprocedural contrast enhanced CBCT may identify responders to TARE in patients with liver metastases.
Le texte complet de cet article est disponible en PDF.Keywords : Therapeutic Embolization, Cone-beam computed tomography, Neoplasm metastasis, Diagnostic imaging
Abbreviations : AEF, ANOVA, AUC, CBCT, CR, CT, DEM, HCC, HU, MBq, MDCT, MRI, PBV, PD, PR, RECIST, ROC, ROI, SD, SPECT, TACE, TARE, Y-90, 3D, 99mTc-MAA
Plan
Vol 1
Article 100005- mars 2022 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.